American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
LAKE FOREST, Ill., Feb. 07, 2018 -- Stericycle, Inc. (NASDAQ:SRCL) will give a presentation on Monday, March 5th by Charlie Alutto, President and CEO and Dan Ginnetti, CFO, at 2:15 PM Eastern time at the Raymond James and Associates 39th Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida.
On Tuesday, March 6th and Wednesday, March 7th Stericycle’s Dan Ginnetti will host one-on-one and group meetings at the Stifel Executive Summit in Streamsong, Florida.
Stericycle’s press releases and other information are available on the Company’s website at www.stericycle.com.
FOR FURTHER INFORMATION CONTACT:
Investor Relations 1-847-607-2012
